A systematic review of primary active surveillance management of low-risk papillary carcinoma

被引:19
|
作者
Alhashemi, Ahmad [1 ]
Goldstein, David P. [2 ,3 ]
Sawka, Anna M. [1 ,4 ]
机构
[1] Univ Toronto, Dept Med, Div Endocrinol, Toronto, ON, Canada
[2] Univ Hlth Network, Dept Otolaryngol Head & Neck Surg, Toronto, ON, Canada
[3] Univ Toronto, Toronto, ON, Canada
[4] Univ Hlth Network, Dept Med, Div Endocrinol, Toronto, ON, Canada
关键词
active surveillance; papillary thyroid cancer; thyroid carcinoma; thyroidectomy; DIFFERENTIATED THYROID-CARCINOMA; THERAPEUTIC STRATEGY; ENDOCRINE SURGEONS; SURGICAL-TREATMENT; JAPANESE SOCIETY; UNITED-STATES; PATIENT AGE; CANCER; MICROCARCINOMA; ASSOCIATION;
D O I
10.1097/CCO.0000000000000244
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose of review Active surveillance is close follow-up of neoplasms, with predetermined intervention triggers. We systematically reviewed the published English language literature on primary active surveillance of low-risk papillary thyroid cancer (PTC). Recent findings We searched seven electronic databases (1980-2015), supplemented with a hand search. Two reviewers independently screened 1715 citations and reviewed 32 full-text papers, ultimately including two papers. Data were independently abstracted. There were two Japanese single-center, single-arm studies reporting on 1235 and 322 patients with PTC microcarcinoma (primary <1 cm in diameter) confined to the thyroid. Mean study follow-up was of 5.0 and 6.5 years, respectively. Disease triggers for thyroidectomy included progression of the primary tumor or incident metastatic disease. The rates of thyroidectomy were 15.5% (191/1235) and 8.7% (28/322) in respective studies. The incidence of primary tumor enlargement >= 3 mm in maximal diameter was 4.6% (58/1235) and 5.0% (16/322). The incidence of nodal metastases was 1.5% (19/1235) and 0.9% (3/322). There were neither reports of PTC-related death nor development of distant metastatic disease. Quality of life, psychosocial health, and economic outcomes were not reported. Summary In two Japanese single-arm studies, active surveillance of PTC microcarcinoma was relatively well tolerated; however, more long-term outcome research is needed.
引用
收藏
页码:11 / 17
页数:7
相关论文
共 50 条
  • [21] Oncological safety of active surveillance for low-risk ductal carcinoma in situ - a systematic review and meta-analysis
    Davey, Matthew G.
    Lowery, Aoife J.
    Kerin, Michael J.
    IRISH JOURNAL OF MEDICAL SCIENCE, 2023, 192 (04) : 1595 - 1600
  • [22] Comparison of the costs of active surveillance and immediate surgery in the management of low-risk papillary microcarcinoma of the thyroid
    Oda, Hitomi
    Miyauchi, Akira
    Ito, Yasuhiro
    Sasai, Hisanori
    Masuoka, Hiroo
    Yabuta, Tomonori
    Fukushima, Mitsuhiro
    Higashiyama, Takuya
    Kihara, Minoru
    Kobayashi, Kaoru
    Miya, Akihiro
    ENDOCRINE JOURNAL, 2017, 64 (01) : 59 - 64
  • [23] Pathological characteristics of low-risk papillary thyroid microcarcinoma with progression during active surveillance
    Hirokawa, Mitsuyoshi
    Kudo, Takumi
    Ota, Hisashi
    Suzuki, Ayana
    Miyauchi, Akira
    ENDOCRINE JOURNAL, 2016, 63 (09) : 805 - 810
  • [24] Long-term outcomes of active surveillance for low-risk papillary thyroid carcinoma: Progression patterns and tumor calcification
    Sugitani, Iwao
    Nagaoka, Ryuta
    Saitou, Marie
    Sen, Masaomi
    Kazusaka, Hiroko
    Matsui, Mami
    Abe, Takeshi
    Ito, Ryo
    Toda, Kazuhisa
    WORLD JOURNAL OF SURGERY, 2025, 49 (01) : 159 - 169
  • [25] Management of Low-Risk Thyroid Cancers: Is Active Surveillance a Valid Option? A Systematic Review of the Literature
    Patrone, Renato
    Velotti, Nunzio
    Masone, Stefania
    Conzo, Alessandra
    Flagiello, Luigi
    Cacciatore, Chiara
    Filardo, Marco
    Granata, Vincenza
    Izzo, Francesco
    Testa, Domenico
    Avenia, Stefano
    Sanguinetti, Alessandro
    Polistena, Andrea
    Conzo, Giovanni
    JOURNAL OF CLINICAL MEDICINE, 2021, 10 (16)
  • [27] Can Active Surveillance Management be Developed for Patients With Low-Risk Papillary Thyroid Microcarcinoma? A Preliminary Investigation in a Chinese Population
    Liu, Wen
    Cao, Weihan
    Dong, Zhizhong
    Cheng, Ruochuan
    ENDOCRINE PRACTICE, 2022, 28 (04) : 391 - 397
  • [28] A Quantitative Analysis Examining Patients' Choice of Active Surveillance or Surgery for Managing Low-Risk Papillary Thyroid Cancer
    Sawka, Anna M.
    Ghai, Sangeet
    Rotstein, Lorne
    Irish, Jonathan C.
    Pasternak, Jesse D.
    Gullane, Patrick J.
    Monteiro, Eric
    Gooden, Everton
    Brown, Dale H.
    Eskander, Antoine
    Zahedi, Afshan
    Chung, Janet
    Su, Jie
    Xu, Wei
    Ihekire, Ogemdi
    Jones, Jennifer M.
    Gafni, Amiram
    Baxter, Nancy N.
    Goldstein, David P.
    THYROID, 2022, 32 (03) : 255 - 262
  • [29] Active surveillance in low risk papillary thyroid carcinoma
    Pitoia, Fabian
    Smulever, Anabella
    WORLD JOURNAL OF CLINICAL ONCOLOGY, 2020, 11 (06): : 320 - 336
  • [30] Active surveillance of low-risk papillary thyroid carcinoma: a promising strategy requiring additional evidence
    Yuyang Ze
    Xiaowen Zhang
    Fei Shao
    Lin Zhu
    Shanmei Shen
    Dalong Zhu
    Yan Bi
    Journal of Cancer Research and Clinical Oncology, 2019, 145 : 2751 - 2759